Dr Nicholas Robert Explains the Need to Standardize Use of RWE for Measuring Clinical End Points

June 23, 2019

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the need for standardizing the use of real-world evidence for measuring endpoints in clinical practice.

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the need for standardizing the use of real-world evidence for measuring endpoints in clinical practice.

Transcript

How do challenges associated with variation in the use of real-world evidence for measuring endpoints in clinical practice highlight the need for standardization, and are there any potential ways that have been identified to do this?

I think harmonization of results from different groups is absolutely necessary. Friends of Cancer Research actually has provided some leadership. They recently did a study looking at the management of lung cancer using multiple groups. They are now doing a second iteration of that, and we’re happy to say that we’re going to be participating and this will be an opportunity to use common terms and see how much overlap of agreement there is from different data sources.